ABSTRACT

Today, the administration of inhaled medications represents the route of choice for applying drugs aimed at respiratory disorders. For the correct application of inhaled drug treatment, the proper selection of the device for each patient is essential, as well as the review of the administration technique. There are different considerations that must be taken into account to ensure that the inhaled therapy is optimal; To know in depth the available devices, their peculiarities and administration technique, as well as to take into account the clinical characteristics, comorbidities, age, inhalation capacity of the patient. There are inhales that require a high inspiratory flow to perform a rapid and deep inhalation, there are others where a slow and constant inhalation must be performed since they do not require a high flow. The goal of this narrative is to review the different inhalers currently available, with the presentation of the types of devices, doses and trade names in our country to facilitate daily practice when prescribing them. In the same way, it reminds the pulmonologist of the importance of knowing the characteristics of each one; and the importance of understanding the needs and capacities of the patient to be able to correctly choose the ideal device.

KEYWORDS

Measured dose, inhalers, pressurized metered dose inhaler, inhaled medications, respiratory therapy.

REFERENCES

1. Lavorini F, Mannini C, Chellini E. Challenges of inhaler use in the treatment of asthma and chronic obstructive pulmonary disease. EMJ Respir. 2015;3(2):98-105.

2. Markus-Borghardt J, Kloft C, Sharma A. Inhaled therapy in respiratory disease: the complex interplay of pulmonary kinetic processes. Can Respir J. 2018;2018:2732017. Available in: https://doi.org/10.1155/2018/2732017

3. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003;16(3):249-254. Available in: https://doi.org/10.1089/089426803769017613

4. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102(4):593-604. Available in: https://doi.org/10.1016/j.rmed.2007.11.003

5. Usmani OS. Choosing the right inhaler for your asthma or COPD patient. Ther Clin Risk Manag. 2019;15:461-472. Available in: https://doi.org/10.2147/tcrm.s160365

6. Weber B, Hochhaus G. A pharmacokinetic simulation tool for inhaled corticosteroids. AAPS J. 2013;15(1):159-171. Available in: https://doi.org/10.1208/s12248-012-9420-z

7. Tsuda A, Henry FS, Butler JP. Particle transport and deposition: basic physics of particle kinetics. Compr Physiol. 2013;3(4):1437-1471. Available in: https://doi.org/10.1002/cphy.c100085

8. Dispositivos de inhalación para asma y EPOC. Bol Ter ANDAL. 2018;33(2):9-19. Disponible en: http://dx.doi.org/10.11119/BTA2017-33-02

9. Labiris NR, Dolovich MB. Pulmonary drug delivery. part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003:56(6):588-599. Available in: https://doi.org/10.1046/j.1365-2125.2003.01892.x

10. Bonini M, Usmani OS. The importance of inhaler devices in the treatment of COPD. COPD Res Pract. 2015;1(9). Available in: https://doi.org/10.1186/s40749-015-0011-0

11. Thompson PJ. Drug delivery to the small airways. Am J Respir Crit Care Med. 1998:157(5 Pt 2):S199-S202. Available in: https://doi.org/10.1164/ajrccm.157.5.rsaa-7

12. Olsson B, Bondesson E, Borgström L, Edsbäcker S. Pulmonary drug metabolism, clearance, and absorption. In: Controlled pulmonary drug delivery. New York, NY: Springer; 21-50. Available in: https://www.researchgate.net/deref/http%3A%2F%2Fdx.doi.org%2F10.1007%2F978-1-4419-9745-6_2

13. Consenso SEPAR-ALAT sobre terapia inhalada. Arch Bronconeumol. 2013;49(Supl 1):2-14. Disponible en: https://doi.org/10.1016/S0300-2896(13)70068-1

14. Cases GS, Aragonés C, Toya AA, Carreño GM, Peiró MJF. Dispositivos y guía de administración vía inhalatoria. Rev OFIL. 2017;27(1):31-46.

15. Sanchis J, Gich I, Pedersen S; Aerosol Drug Management Improvement Team (ADMIT). Systematic review of errors in inhaler use: has patient technique improved over time? Chest. 2016;150(2):394-406. Available in: https://doi.org/10.1016/j.chest.2016.03.041

16. Miravitlles M, Soler-Cataluña JJ, Alcázar B, Viejo JL, Gracía-Río F. Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus. Pulm Pharmacol Ther. 2018;48:97-103. Available in: https://doi.org/10.1016/j.pupt.2017.10.006